Market Overview and Recent Performance of Jin Ji (300798.SZ)

During the 24‑hour window concluding at 10:25 AM Central European Time on Thursday, 22 March, Jin Ji’s share price remained unchanged, registering a 0 % movement. The stock is currently available for purchase at approximately CNY 7.25 on major exchanges.

With a circulating supply of 488.7 million shares, Jin Ji’s market capitalisation stands at roughly CNY 3.9 billion. In the past day, the trading volume has reached CNY 703.2 million, indicating a moderate level of liquidity despite the flat price action.

Since the end of the previous month, Jin Ji has experienced an 11.63 % decline, underscoring a broader downward trend in the company’s valuation. The 200‑day simple moving average, a commonly used trend‑indicator, is presently at CNY 7.56, suggesting that the current price is slightly below the medium‑term average.

The company’s most recent peak within the past year was CNY 13.42, recorded on 16 April 2026, while the lowest point reached CNY 5.62 on 21 July 2026. These extremes highlight the stock’s volatility over a 52‑week period.

Comparative Performance of Peer Stocks

The following table summarises the 24‑hour performance of several peer companies, providing context for Jin Ji’s position within its sector:

CompanyTicker24‑hour changeCurrent price (CNY)Market capitalisation (CNY)Price/Earnings (P/E)
Gem‑Year Industrial601002.SSFlat (0 %)4.874.7 bn14.33
Hunan Fangsheng Pharmaceutical603998.SSFlat (0 %)10.244.7 bn13.78
Beijing Thunisoft300271.SZFlat (0 %)5.674.7 bn–
Tianjin Teda Rec000652.SZFlat (0 %)3.144.7 bn–
Zhejiang Hechuan Technolog688320.SSFlat (0 %)31.174.7 bn–

All of the peer stocks experienced a neutral price movement in the same 24‑hour period, mirroring Jin Ji’s lack of volatility. However, the companies differ significantly in valuation metrics and trading volumes, which could influence investor sentiment and liquidity.

Investor Implications

For investors monitoring Jin Ji, the flat price movement and the current trading price close to the 200‑day moving average suggest a period of consolidation. The sustained decline from the end of the previous month raises questions about the company’s recent fundamentals and market perception.

Comparatively, peers exhibit similar price stability but vary in valuation multiples; for instance, Gem‑Year Industrial and Hunan Fangsheng Pharmaceutical maintain moderate P/E ratios around 14, indicating a more balanced earnings outlook than some of the other peers where P/E data is unavailable.

Given the current market cap of CNY 3.9 billion and the modest trading volume of CNY 703.2 million, liquidity is adequate for most institutional and retail investors, yet the recent price dip warrants a cautious approach. Investors should monitor earnings releases, strategic developments, and broader market trends to assess whether the current price represents a buying opportunity or a signal of continued weakness.

Prepared for corporate investors and market analysts seeking an in‑depth snapshot of Jin Ji’s recent trading activity and its position relative to sector peers.